openPR Logo
Press release

Whole Genome and Exome Sequencing Market to Surge to USD 4,719.86 Million by 2030, Growing at a CAGR of 21.20% from 2022: Data Bridge Market Research

Whole Genome and Exome Sequencing Market to Surge to USD 4,719.86

The "Whole Genome and Exome Sequencing Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats, alongside political, economic, social, technological, environmental, and legal factors. Expert opinions and recent developments highlight the geographical distribution and forecast the market's trajectory, ensuring a robust foundation for strategic planning and investment.

What is the projected market size & growth rate of the Whole Genome and Exome Sequencing Market?

Market Analysis and Size

The key factors driving the global whole exome sequencing market are increasing applications in clinical diagnosis and the growing demand for diagnosing rare diseases, increasing R&D in genomics and next-generation sequencing, and rising demand for personalized medicine. For instance, an article published in the British Medical Journal in March 2022 reported that whole exome sequencing is available for highly selected patients for the routine diagnosis of rare childhood genetic diseases. The article also said that next-generation sequencing allows hundreds or thousands of genes to be sequenced quickly at a much lower cost. Due to the benefits of exome sequencing, the studied market is expected to grow over the forecast period.

Moreover, the growing adoption of personalized medicine is further estimated to provide potential opportunities for the growth of the whole genome and exome sequencing market in the forecast period.

Data Bridge Market Research analyses that the whole genome and exome sequencing market, which was USD 1,099.22 million in 2022, is likely to reach USD 4,719.86 million by 2030 and is expected to undergo a CAGR of 21.20% during the forecast period. This indicates that the market value. "Hospitals and Clinics" dominate the end-user segment of the whole genome and exome sequencing market due to the growing demand for products. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Browse Detailed TOC, Tables and Figures with Charts which is spread across 350 Pages that provides exclusive data, information, vital statistics, trends, and competitive landscape details in this niche sector.

This research report is the result of an extensive primary and secondary research effort into the Whole Genome and Exome Sequencing market. It provides a thorough overview of the market's current and future objectives, along with a competitive analysis of the industry, broken down by application, type and regional trends. It also provides a dashboard overview of the past and present performance of leading companies. A variety of methodologies and analyses are used in the research to ensure accurate and comprehensive information about the Whole Genome and Exome Sequencing Market.

Get a Sample PDF of Report -

Which are the driving factors of the Whole Genome and Exome Sequencing market?

The driving factors of the Whole Genome and Exome Sequencing market include technological advancements that enhance product efficiency and user experience, increasing consumer demand driven by changing lifestyle preferences, and favorable government regulations and policies that support market growth. Additionally, rising investment in research and development and the expanding application scope of Whole Genome and Exome Sequencing across various industries further propel market expansion.

Whole Genome and Exome Sequencing Market - Competitive and Segmentation Analysis:

Global Whole Genome and Exome Sequencing Market, By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Others), Products and Services (Products, Systems, Kits, Services, Sequencing Services, Data Analysis Services, Others), Applications (Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, Others), End User (Research Center, Academic and Government Institutions, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others) - Industry Trends and Forecast to 2031.

How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Which are the top companies operating in the Whole Genome and Exome Sequencing market?

Some of the major players operating in the whole genome and exome sequencing market are:

Neusoft Corporation (China)
SurgicEye GmbH (Germany)
Mediso Ltd. (Hungary)
CMR Naviscan. (U.S.)
DDD-Diagnostic A/S (Denmark)
Absolute Imaging Inc. (Canada)
Bartec Technologies Ltd. (U.K.)
BCL X-Ray Canada Inc. (Canada)
TTG Imaging Solutions, LLC (U.S.)
Mirion Technologies (Capintec), Inc. (U.S.)
Ashby Gorman Baker Ltd. (Belgium)
Lucerno Dynamics, LLC. (U.S.)
Berthold Technologies GmbH & Co.KG (Germany)
Incom, Inc. (U.S.)
Siemens (U.S.)
Koninklijke Philips N.V. (Netherlands)
Spectrum Dynamics Medical (Switzerland)
Short Description About Whole Genome and Exome Sequencing Market:

The Global Whole Genome and Exome Sequencing market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

North America, especially The United States, will still play an important role which can not be ignored. Any changes from United States might affect the development trend of Whole Genome and Exome Sequencing. The market in North America is expected to grow considerably during the forecast period. The high adoption of advanced technology and the presence of large players in this region are likely to create ample growth opportunities for the market.

Europe also play important roles in global market, with a magnificent growth in CAGR During the Forecast period 2024-2031.

Whole Genome and Exome Sequencing Market size is projected to reach Multimillion USD by 2031, In comparison to 2024, at unexpected CAGR during 2024-2031.

Despite the presence of intense competition, due to the global recovery trend is clear, investors are still optimistic about this area, and it will still be more new investments entering the field in the future.

This report focuses on the Whole Genome and Exome Sequencing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Get a Sample Copy of the Whole Genome and Exome Sequencing Report 2024

What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report. Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users. Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2024-2031) of the following regions are covered in Chapters

What are the key regions in the global Whole Genome and Exome Sequencing market?

North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
This Whole Genome and Exome Sequencing Market Research/Analysis Report Contains Answers to your following Questions

What are the global trends in the Whole Genome and Exome Sequencing market?
Would the market witness an increase or decline in the demand in the coming years?
What is the estimated demand for different types of products in Whole Genome and Exome Sequencing?
What are the upcoming industry applications and trends for Whole Genome and Exome Sequencing market?
What Are Projections of Global Whole Genome and Exome Sequencing Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about Import and Export?
Where will the strategic developments take the industry in the mid to long-term?
What are the factors contributing to the final price of Whole Genome and Exome Sequencing?
What are the raw materials used for Whole Genome and Exome Sequencing manufacturing?
How big is the opportunity for the Whole Genome and Exome Sequencing market?
How will the increasing adoption of Whole Genome and Exome Sequencing for mining impact the growth rate of the overall market?
How much is the global Whole Genome and Exome Sequencing market worth? What was the value of the market In 2020?
Who are the major players operating in the Whole Genome and Exome Sequencing market? Which companies are the front runners?
Which are the recent industry trends that can be implemented to generate additional revenue streams?
What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Whole Genome and Exome Sequencing Industry?
Customization of the Report

Can I modify the scope of the report and customize it to suit my requirements? Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Detailed TOC of Global Whole Genome and Exome Sequencing Market Insights and Forecast to 2031

Market Segmentation
Executive Summary
Premium Insights
Market Overview
Whole Genome and Exome Sequencing Market By Type
Whole Genome and Exome Sequencing Market By Function
Whole Genome and Exome Sequencing Market By Material
Whole Genome and Exome Sequencing Market By End User
Whole Genome and Exome Sequencing Market By Region
Whole Genome and Exome Sequencing Market: Company Landscape
SWOT Analysis
Company Profiles
Purchase this report -

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 975


This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Whole Genome and Exome Sequencing Market to Surge to USD 4,719.86 Million by 2030, Growing at a CAGR of 21.20% from 2022: Data Bridge Market Research here

News-ID: 3547461 • Views:

More Releases from Data Bridge Market Research (DBMR)

Chromatography Columns Market would rocket up to USD 18,989.02 million by 2030,I …
Chromatography columns are solid-filled glass tubes that are used to separate distinct components of a liquid sample. It is an analytical method for separating a mixture of chemical components into single, self-contained compounds. Chromatography columns are used to purify chemical compound mixtures. View Detailed Report" Surging pharmaceutical research and development investments contribute to the chromatography column market's growth rate globally. Moreover, the key players are highly focused on various advancements and
Weight Management Market to reach the value of USD 421.57 billion by the year 20 …
Weight management, as the name implies, is the use of techniques, equipment, changing consumption patterns, and other methods to manage one's weight in accordance with one's body structure, height, and desires. Weight management techniques advocate for weight management based on age, height, and gender. View Detailed Report" Data Bridge Market Research analyses that the weight management market is expected to reach the value of USD 421.57 billion by the year 2029,
Engineered Quartz Surface Market to undergo a CAGR of 8.65%, size, business oppo …
Quartz refers to a premium material and the finished product including non-allergenic and non-toxic, which lasts a lifetime and decreases the need for replacement. It is considered manmade product that is obtained from natural materials. The product is made 90% - 94% from ground quartz and 6% - 10% colors. Resins are combined into long-lasting and nonporous slabs. The engineered quartz is organically resistant to scratches, abrasion, dents, and even
Anime Market CAGR of 8.50% during the forecast period
Anime Market CAGR of 8.50% during the forecast period
The report is designed to provide a holistic view of the Anime Market . It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, South

All 5 Releases

More Releases for Sequencing

Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Get Research Sample PDF at Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period. Metagenomics, is a field where genomic analysis of microbial DNA
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Precision Medicine Market Report 2018: Segmentation by Technology (Genomics, Tra …
Global Precision Medicine market research report provides company profile for Abbott Laboratories, Almac Group, Ltd, Asuragen, Inc., Cepheid Inc, Cetics Healthcare Technologies GmbH, Ge Healthcare, Glaxosmithkline Plc, Intomics A/S., Biocrates Life Sciences Ag, Pfizer Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Next Generation Sequencing (NGS) Market, By Technology (Whole Exon Sequencing (W …
The next generation sequencing market is estimated to represent a global market of USD 5,618 million by 2017 with growth rate of 9.1%. Next-generation sequencing (NGS) involves an advanced level of genetic sequencing which is a level above the conventional methods such as capillary electrophoresis-based Sanger sequencing. NGS procedure is a multi-step process where a number of smaller laboratory processes combine to form the whole next-generation sequencing process. This includes
Next Generation Sequencing Market Global Analysis and Forecasts by Service (Geno … has announced the addition of the “Next Generation Sequencing Market to 2025”, the report classifies the global Next Generation Sequencing Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth. The next generation market is estimated to account for US$ 26,501.2 Mn by the end of 2025, escalating at a CAGR of 21.1% during the